Return to homepagePandemic Pact

Testing Ervebo vaccine and Zaire Ebola survivor samples for Bundibugyo virus cross-protection

  • Funded by Coalition for Epidemic Preparedness Innovations (CEPI)
  • Total publications:0 publications

Grant number: N/A

Grant search

Key facts

  • Disease

    Ebola

  • Start & end year

    N/A

  • Known Financial Commitments (USD)

    $975,000

  • Funder

    Coalition for Epidemic Preparedness Innovations (CEPI)

  • Principal Investigator

    Miles Carroll

  • Research Location

    United Kingdom

  • Lead Research Institution

    University of Oxford, Nuffield Department Centre for Human Genetics and Pandemic Sciences Institute

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Post acute and long term health consequences

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Study of samples from Ervebo vaccine recipients and survivors of Zaire Ebola virus disease to assess potential cross-protective immune responses against Bundibugyo virus.